Study registration: *
Publication Rosenberg E, MMWR, 2021
Dates: 2020-12-01 to 2021-07-25
Funding: Not reported/unclear
Conflict of interest: no COI (No potential conflicts of interest were disclosed.)

Methods

Study design:Cohort
Description of participants: Adults aged ≥18 years residing in New York state in multiple centres in USA
Inclusion criteria:
  • All adults aged ≥18 years
  • residing in New York state
  • assessed for outcomes between July 19-25, 2021.

Exclusion criteria:
  • Previous SARS-CoV-2 positive result within 90 days
  • partially vaccinated.

Follow-up duration (months): 7.87
Vaccines:
  • 2 doses of BNT162b2 or mRNA-1273 or 1 dose of Ad26.COV2.S
Variant description :
Variant name: Delta
Evidence: Indirect evidence (prevalence of variant in the population: 95%)
Documents
available

Protocol

NR

Statistical plan

NR

Data-sharing stated: NR
Data accessibility: NR
General comment Concerns mainly over uncontrolled confounding.